CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service · Privacy FAQ

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Valink Therapeutics
Valink Therapeutics

Valink Therapeutics

Discovering bispecific antibodies for cancer treatment through innovative antibody modifications for solid tumors.

Operating headquarters
Cambridge, MA, US🇺🇸
Founded
2021
Accelerator
Y Combinator logoY CombinatorW21
Overview
Compare
Fundraising
Employees
Library

Valink Therapeutics, founded with a mission to revolutionize cancer treatment, focuses on developing next-generation antibody-based therapeutics. The company specializes in discovering bispecific antibody drug-conjugates (BsADC) targeting solid tumors that are poorly addressed by current immunotherapies. By incorporating multiple antibody modifications simultaneously, Valink Therapeutics rapidly and scalably generates complex drug candidates with bi-/multispecificity, multivalency, and drug-conjugation.

Notable figures affiliated with Valink Therapeutics include leading scientists and industry experts in oncology and biotechnology. The company has secured investments from prominent venture capital firms specializing in life sciences. Key achievements include the successful identification of novel mechanisms of action from known targets and the development of promising therapeutic candidates. Valink Therapeutics' innovative approach has the potential to significantly impact the treatment landscape for solid tumors, offering new hope for patients with limited options.

Valink Therapeutics - Similar Companies

Valitor logo

Valitor

valitorbio.com

Velorum Therapeutics logo

Velorum Therapeutics

velorumtx.com

Rondo Therapeutics logo

Rondo Therapeutics

rondotx.com

Solve Therapeutics logo

Solve Therapeutics

Adventris Pharmaceuticals logo

Adventris Pharmaceuticals

adventris.com

Catena Biosciences logo

Catena Biosciences

Aarvik Therapeutics logo

Aarvik Therapeutics

aarviktx.com

LiliumX logo

LiliumX

liliumx.com

Crossbow Therapeutics logo

Crossbow Therapeutics

crossbowtx.com

Vivace Therapeutics logo

Vivace Therapeutics

Adcentrx Therapeutics logo

Adcentrx Therapeutics

adcentrx.com

Launchpad Therapeutics logo

Launchpad Therapeutics

Eris Biotech logo

Eris Biotech

erisbio.com

Modifi Bio logo

Modifi Bio

modifibio.com

Resonant Therapeutics logo

Resonant Therapeutics

resonantrx.com

Valink Therapeutics - Quick Facts

Who are Valink Therapeutics' competitors?

Companies similar to Valink Therapeutics include Valitor, Velorum Therapeutics, Rondo Therapeutics and Solve Therapeutics.

When was Valink Therapeutics founded?

Valink Therapeutics was founded in 2021.

Where is Valink Therapeutics' headquarters located?

Valink Therapeutics' headquarters is located in Cambridge, MA, US.

When was Valink Therapeutics' last funding round?

Valink Therapeutics' most recent funding round was for $125k (USD) in January 2021.

How much has Valink Therapeutics raised to-date?

As of Jan 1, 2021, Valink Therapeutics has raised a total of $125k (USD).

How many employees does Valink Therapeutics have?

Valink Therapeutics has 12 employees as of Apr 8, 2024.

Valink Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Therapeutics
Tags
  • Biotech